Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.

Nephrology (Carlton, Vic.) - 1 Jul 2011

Lee Yu-Ji, Jang Hye Ryoun, Kim Seong Gyun, Chae Dong-Wan, Do Jun-Young, Lee Jung Eun, Huh Wooseong, Kim Dae Joong, Oh Ha Young, Kim Yoon-Goo

Abstract excerpt

AIM: The renoprotective effects of angiotensin receptor blockers vary considerably among individuals. We investigated the renoprotective effects of valsartan according to polymorphisms of the renin-angiotensin system and transforming growth factor-b1 (TGFB1) genes in patients with chronic non-diabetic proteinuric nephropathies. METHODS: Two hundred and thirty-nine non-diabetic patients with proteinuria of at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin II Type 1 Receptor Blockers
Share to Angiotensinogen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Protective Agents

Share to Proteinuria

Share to Receptor, Angiotensin, Type 1

Share to Renin-Angiotensin System

Share to Tetrazoles

Share to Transforming Growth Factor beta1

Source

Identifiers

PMID: 21303424
DOI: 10.1111/j.1440-1797.2011.01448.x

Genes

TGFB1
ACE
AGT

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms.PMID 21303424Read ↗

The association of ACE gene polymorphism with diabetic kidney disease and renoprotective efficacy of valsartan.Semantic proximity Read ↗

The influence of renin-angiotensin system genotypes on the antiproteinuric response to high doses of olmesartan in non-diabetic proteinuric nephropathies.Semantic proximity Read ↗

[The relationship between the gene polymorphism of TGF-beta1 and early renal injury in patients with essential hypertension, and the effect of the gene polymorphism of TGF- beta1 on the individual treatment with valsartan].Semantic proximity Read ↗

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.Semantic proximity Read ↗

[Pharmacogenetics of angiotensin system in non diabetic nephropathy].Semantic proximity Read ↗

Gene polymorphisms as clinical tools in chronic glomerulopathies: a prospective study.Semantic proximity Read ↗

The effect of polymorphisms in the renin-angiotensin-aldosterone system on diabetic nephropathy risk.Semantic proximity Read ↗

Association between genetic variation in transforming growth factors beta1 and beta3 and renal dysfunction in non-diabetic Chinese.Semantic proximity Read ↗

Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.Semantic proximity Read ↗

ACE insertion/deletion polymorphism (rs1799752) modifies the renoprotective effect of renin-angiotensin system blockade in patients with IgA nephropathy.Semantic proximity Read ↗

Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?Semantic proximity Read ↗

Association of TGF-beta1 polymorphisms with chronic renal disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.